Swedish Household Products Stock News

OM:GETI B
OM:GETI BMedical Equipment

A Look At Getinge (OM:GETI B) Valuation After Recent Mixed Share Price Performance

Getinge (OM:GETI B) has drawn fresh attention after recent share performance, with the stock showing mixed returns over the past month and the past three months while value focused investors reassess its current pricing. See our latest analysis for Getinge. At a share price of SEK188.55, Getinge’s recent 7 day share price return of 2.6% contrasts with its 30 day share price return of a 7.1% decline and its 1 year total shareholder return of a 13.1% loss. This suggests momentum has been fading...
OM:CLA B
OM:CLA BFood

Cloetta (OM:CLA B) Valuation Check After Higher Dividend Proposal And Insider Buying Interest

Cloetta (OM:CLA B) has come into focus after the board proposed a dividend of SEK 1.40 per share, up from SEK 1.10, alongside growing attention on insider buying and perceived undervaluation. See our latest analysis for Cloetta. At a share price of SEK53.05, Cloetta has delivered a 31.12% 90 day share price return and an 89.19% 1 year total shareholder return, suggesting momentum has been building around the higher proposed dividend and insider interest. If this kind of upswing has you...
OM:HOFI
OM:HOFIConsumer Finance

Is Hoist Finance (OM:HOFI) Still Undervalued After The HoistSpar Expansion Into Spain

Hoist Finance (OM:HOFI) has just introduced HoistSpar in Spain, offering online euro fixed rate savings accounts with 3 to 24 month terms. All deposits are covered by the Swedish deposit guarantee scheme. See our latest analysis for Hoist Finance. The HoistSpar launch in Spain comes after a strong run in Hoist Finance's shares, with a 31.21% 90 day share price return and a very large 3 year total shareholder return. This suggests that momentum has been building rather than fading. If this...
OM:SOBI
OM:SOBIBiotechs

EMA Tryngolza Review And Gamifant Data Reframe Sobi’s Growth Story

EMA validates Sobi’s application to extend Tryngolza (olezarsen) to adults with severe hypertriglyceridemia, supported by pivotal Phase 3 data. Tryngolza’s extended indication targets patients at risk of acute pancreatitis where existing treatments often fall short. New Phase 2a data for Gamifant (emapalumab) in IFN-gamma-driven sepsis are presented at ISICEM, covering inflammation-related organ dysfunction and mortality outcomes. Both updates highlight late stage pipeline progress for...
OM:ORES
OM:ORESDiversified Financial

Global's Undervalued Small Caps With Insider Action In March 2026

Amidst a backdrop of geopolitical tensions and fluctuating energy prices, global markets have experienced mixed performances, with small-cap indices like the S&P MidCap 400 and Russell 2000 showing resilience by closing higher after a series of losses. As investors navigate these volatile conditions, identifying small-cap stocks that demonstrate strong fundamentals and insider activity can offer potential opportunities for those looking to capitalize on market inefficiencies.
OM:FABG
OM:FABGReal Estate

Fabege (OM:FABG) Valuation Check After Proposed 2025 Quarterly Dividend Announcement

Fabege (OM:FABG) is back on income investors’ radar after the board proposed a 2025 dividend of SEK 2.20 per share, to be paid in four quarterly instalments, subject to AGM approval. See our latest analysis for Fabege. The proposed 2025 dividend comes as Fabege’s share price sits at SEK75.05 after a 2.25% 1 day share price return, with short term momentum soft and longer term total shareholder returns mixed. This suggests sentiment is still recalibrating around income and risk. If this...
OM:INTEA B
OM:INTEA BReal Estate

European Undervalued Small Caps With Insider Buying For March 2026

As European markets navigate the uncertainty surrounding the Middle East conflict and its impact on energy prices, small-cap stocks have drawn attention for their potential resilience and growth opportunities. In this environment, identifying undervalued small-cap companies with insider buying can be a strategic approach to finding promising investments amid broader market volatility.
OM:VIMIAN
OM:VIMIANMedical Equipment

March 2026 European Stocks Trading At Estimated Discounts

As European markets navigate the uncertainty surrounding the Middle East conflict and its impact on economic growth, investors are keenly observing how these developments influence stock valuations. In this context, identifying undervalued stocks becomes crucial, as they may present opportunities for those looking to capitalize on potential market inefficiencies amid ongoing geopolitical and economic challenges.
OM:EVO
OM:EVOHospitality

Is Evolution’s 2025 Dividend Pause Reframing Its Capital Allocation Priorities For Evolution (OM:EVO)?

In March 2026, Evolution AB’s Board of Directors proposed that no dividend be distributed for the 2025 financial year, marking a clear pause in cash returns to shareholders. This decision puts renewed focus on how Evolution intends to deploy its cash between growth investments, regulatory demands, and shareholder returns. We’ll now examine how the proposed suspension of the 2025 dividend could reshape Evolution’s investment narrative and capital allocation story. The best AI stocks today...
OM:GETI B
OM:GETI BMedical Equipment

Is It Time To Reassess Getinge (OM:GETI B) After Its Recent Share Price Weakness

If you are wondering whether Getinge's share price matches the underlying value of the business, the next sections will walk through what the numbers are currently saying about that gap. Over recent periods the stock has been mixed, with a 1.3% return over 7 days, a 9.1% decline over 30 days, a 15.2% decline year to date, and a 12.3% decline over the past year. These moves come as investors continue to reassess medical equipment makers like Getinge, with sentiment often shifting quickly when...
OM:SHB A
OM:SHB ABanks

Assessing Svenska Handelsbanken (OM:SHB A) Valuation After Approval Of SEK 17.50 Dividend

Dividend decision at AGM puts Svenska Handelsbanken (OM:SHB A) in focus Svenska Handelsbanken (OM:SHB A) came into focus after shareholders approved a total dividend of SEK 17.50 per share at the 25 March 2026 annual general meeting, combining an ordinary payout and a distribution of remaining profits. See our latest analysis for Svenska Handelsbanken. The dividend decision comes after a weaker recent run in the share price. The 30 day share price return is 17.63% and the year to date share...
OM:SECU B
OM:SECU BCommercial Services

Assessing Securitas (OM:SECU B) Valuation After Recent Share Price Volatility

Why Securitas (OM:SECU B) is on investors’ radar today Securitas (OM:SECU B) has drawn attention after recent share price moves, with the stock showing mixed short term performance. At the same time, longer term total returns and reported earnings trends give investors more to unpack. See our latest analysis for Securitas. Recent trading has been choppy, with the share price at SEK155.75 after a 5.5% 7 day share price return, a 3.1% 30 day share price decline and a 13.5% 1 year total...
OM:HEXA B
OM:HEXA BElectronic

Hexagon Plans Octave Spin Off As Valuation And Governance Questions Grow

Hexagon (OM:HEXA B) has announced plans to spin off its Octave business into a separately listed company, with completion targeted for May 2026 pending shareholder approval. An Investor Day has set out Octave's standalone growth strategy, including a focus on recurring revenue and profitability objectives after the spin. Long-time board member Ola Rollén has declined re-election ahead of Hexagon's upcoming AGM, marking a significant change in the company's governance. Hexagon, known for its...
OM:SECU B
OM:SECU BCommercial Services

Securitas (OM:SECU B) Margins Hold At 3.3% And Test Bullish Earnings Growth Narratives

Securitas (OM:SECU B) has put fresh numbers on the table for FY 2025, with Q4 revenue at about SEK 38.4b, Basic EPS of SEK 2.98 and net income of SEK 1,708m setting the tone for the full year. Over the last six reported quarters, revenue has moved between SEK 38.4b and SEK 41.8b while quarterly EPS has ranged from SEK 1.09 to SEK 2.98. This gives investors a clear view of how top line scale and per share earnings have tracked together into the latest print. With a trailing twelve month net...
OM:SIVE
OM:SIVESemiconductor

A Look At Sivers Semiconductors (OM:SIVE) Valuation After New Co‑Packaged Optics Partnership In AI Datacenters

Why this new Co-Packaged Optics partnership matters for Sivers Semiconductors Sivers Semiconductors (OM:SIVE) has been in focus after announcing a partnership with O-Net Technologies and Enablence Technologies to develop an external light source module for Co-Packaged Optics in AI datacenters and high performance computing systems. The collaboration combines Sivers laser arrays with Enablence's NxN Star Coupler, with O-Net acting as the original design manufacturer. The company will integrate...
OM:EVO
OM:EVOHospitality

Assessing Evolution’s (OM:EVO) Valuation After The Board’s 2025 Dividend Cancellation Proposal

Dividend decision shifts focus to Evolution’s capital allocation Evolution (OM:EVO) has proposed that no dividend be distributed for 2025, marking a clear break from regular cash payouts and placing capital allocation and business priorities at the center of investor attention. This kind of dividend decision often matters most to income focused holders, since it can change the appeal of the shares compared with other options that still provide regular cash distributions. See our latest...
OM:GETI B
OM:GETI BMedical Equipment

Getinge’s 2025 Report Highlights Key CE And MDR Progress For Cardiosave

Getinge has released its 2025 Annual Report, highlighting key regulatory milestones for its cardiovascular devices. The company reports that the CE certificate for its intra aortic balloon pump Cardiosave has been reinstated. Getinge has also secured several new MDR approvals, signaling progress in meeting updated European regulatory requirements. For investors following OM:GETI B, these regulatory updates come at a share price of SEK187.0 and a mixed return profile. The stock is up 2.5%...
OM:EQT
OM:EQTCapital Markets

EQT Weighs Diverse M&A Deals And U.S. Logistics To Shape Growth

EQT (OM:EQT) has been linked to several M&A discussions, including potential deals involving Vitabiotics and Happiest Minds Technologies. The company is also reported to have interest in clinical research provider Nucleus Network. Alongside these talks, EQT announced the acquisition of a logistics real estate portfolio in the U.S. The current EQT share price is SEK289.0, with a 4.6% return over the past week and 6.3% over the past month. For investors tracking EQT, the recent cluster of M&A...
OM:PDX
OM:PDXEntertainment

High Growth European Tech Stocks To Watch In March 2026

As European markets navigate heightened uncertainty amid geopolitical tensions and rising energy costs, the pan-European STOXX Europe 600 Index has seen a decline of 3.79%, with major indexes in Germany, Italy, France, and the UK also experiencing notable drops. In this environment of volatility and inflation concerns, investors might find it beneficial to focus on high-growth tech stocks that demonstrate resilience through innovation and adaptability to changing market dynamics.
OM:SYSR
OM:SYSRBuilding

March 2026's Global Undervalued Small Caps With Insider Buying

As global markets navigate a volatile landscape marked by geopolitical tensions, inflation concerns, and fluctuating energy prices, small-cap stocks have experienced varied impacts. The S&P 600 Index for small-cap stocks reflects this uncertainty with recent declines, yet these conditions can present unique opportunities for discerning investors seeking value in the market. Identifying promising small-cap companies often involves looking at strong fundamentals and insider buying trends that...
OM:EMBRAC B
OM:EMBRAC BEntertainment

European Undervalued Small Caps With Insider Action In March 2026

Amidst heightened geopolitical tensions and soaring energy prices, European markets have experienced significant volatility, with the STOXX Europe 600 Index declining by 3.79% in March 2026. As investors navigate these challenging conditions, identifying small-cap stocks that are undervalued and exhibit insider action can be a strategic approach to uncovering potential opportunities within the region's dynamic economic landscape.
OM:SEB A
OM:SEB ABanks

Is Skandinaviska Enskilda Banken (OM:SEB A) Offering Value After Recent Share Price Weakness

Investors may be considering whether Skandinaviska Enskilda Banken is attractively priced right now, or if the recent share moves are signaling a potential concern about value. The stock last closed at SEK170.45, with recent returns showing a 6% decline over 7 days, 11.8% over 30 days and 13.9% year to date, while the 1 year and 3 year returns stand at 15.2% and 95.9% respectively. Those price moves sit against a backdrop of ongoing coverage of Nordic banks and investor interest in how large...